Navigation and service

You are here:Rote-Hand-Briefe and Information Letters

Information letter on Actilyse® powder and solvent for solution for injection and infusion (alteplase) for acute ischaemic stroke: Important extension of indication to include adolescents under 16 years of age

Date 2018.06.22
Active substance alteplase

Actilyse® has been licensed for treatment of acute ischaemic stroke in adolescent patients under 16 years of age.